«BioEq» team attended the «RBK» conference 2014 and performanced the report.
«BioEq» is a first dedicated clinical research unit for early and late stage trials. «BioEq» focuses on bioequivalence, therapeutic equivalence and phase I-IV studies.
«BioEq» will be represented by Business Development team, who will be keen to meet with pharmaceutical and biotech companies to discuss phase I-III clinical trials in Russia.
To set up a meeting please contact us at bd@bioeq.ru
Looking forward to seeing you at the «RBK» conference!